Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 clinical trial involving AIM's Ampligen® (rintatolimod) and AstraZeneca's anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) in the treatment of late-stage pancreatic cancer ("DURIPANC")Watch the "What This Means" segment here OCALA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that AIM CEO ...

PALM BEACH, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The growing adoption of the digital technologies in the healthcare sector owing to the growing need for reducing the healthcare costs and offer enhanced quality patient care services to the patients are the prominent factors that are boosting the growth of the global artificial intelligence in healthcare market. The surging prevalence of various chronic diseases and growing elderly population is resulting in the increased p ...

Miami is the 3rd most visited cruise port as per Visited, travel app which published the most visited cruise ports in the worldTORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Visited app, a travel list app published by Arriving In High Heels Corporation, announces the publication of its Top 25 Most Visited cruise ports list, based on international travelers cruising. The app was developed to keep track of all countries visited, it has later expanded to include US states that users have been to and destinations a ...

Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 clinical trial involving AIM’s Ampligen® (rintatolimod) and AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) in the treatment of late-stage pancreatic cancer (“DURIPANC”)Watch the “What This Means” segment here OCALA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced th ...

Continues Momentum with Deployment of Fully Autonomous AI-Powered Commercial Cleaning RobotsSINGAPORE, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. ("Primech AI"), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), proudly announces the signing of three important pilot program agreements for its groundbreaking HYTRON AI-powered cleaning robots. These agreements with established Singapore-based cleaning companies, including a leading provider of facilities and industrial services operating ac ...

Global investment management firm modernizing investor relations with AI-powered fundraising solutionsPALO ALTO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Intapp (NASDAQ: INTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets, and legal firms, announces that New Forests has implemented Intapp DealCloud to modernize its investor relations and fundraising functions. New Forests is a global investment manager of nature-based real assets and natural capital strat ...

THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISTRIBUTED OR DISSEMINATED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. This press release does not constitute an offer to purchase or subscribe for the Bonds (as defined below) or the shares of VINCI (together, the "Securities") in the United States of America or to, or for the account or benefit of, U.S. persons (as defined in the U.S. Securities Act of 1933, as amended). The Securities may not be offered or s ...

PASADENA, CALIF., Feb. 11, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical stage pharmaceutical company, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 434,784 shares of its common stock at a purchase price of $2.415 per share, in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered w ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Yelp Inc. (YELP) is slated to report fourth-quarter 2024 results after market close on Feb. 13.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.For the fourth quarter, the company anticipates revenues between $347 million and $352 million. The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $350.7 million, indicating a year-over-year increase of 2.4%.The consensus mark for earnings is pegged at 51 cents per share, suggesting a 37.8% year-over-year increase. The cons ...